about
DNA vaccine constructs against enterovirus 71 elicit immune response in miceLong term physiologic modification using rAAV in utero gene-therapyDurable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 +/- IL-15Effects of recombinant adenovirus-mediated expression of IL-2 and IL-12 in human B lymphoma cells on co-cultured PBMCElectroporation by nucleofector is the best nonviral transfection technique in human endothelial and smooth muscle cells.Novel non-viral method for transfection of primary leukemia cells and cell linesEvaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax.The recombinant adeno-associated virus vector (rAAV2)-mediated apolipoprotein B mRNA-specific hammerhead ribozyme: a self-complementary AAV2 vector improves the gene expressionChitosan IFN-gamma-pDNA Nanoparticle (CIN) Therapy for Allergic AsthmaSkipping the co-expression problem: the new 2A "CHYSEL" technologyHuman cytomegalovirus plasmid-based amplicon vector system for gene therapyThe significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer eventsIn vivo gene targeting of IL-3 into immature hematopoietic cells through CD117 receptor mediated antibody gene deliveryDNA vaccines: designing strategies against parasitic infectionsRecombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescueA dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant gliomaThe use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene deliveryImproved gene delivery to human saphenous vein cells and tissue using a peptide-modified adenoviral vectorComparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cellsHuman cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transferGenetic therapy: on the brink of a new futureDNA vaccines: improving expression of antigensRegulatable systemic production of monoclonal antibodies by in vivo muscle electroporationA trial of somatic gene targeting in vivo with an adenovirus vector.Silencing the epidermal growth factor receptor gene with RNAi may be developed as a potential therapy for non small cell lung cancer.Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas.Immediate transfection of patient-derived leukemia: a novel source for generating cell-based vaccinesA combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses.Tissue distribution of a plasmid DNA encoding Hsp65 gene is dependent on the dose administered through intramuscular delivery.A brief review on dengue molecular virology, diagnosis, treatment and prevalence in PakistanApplication of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line.Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5.Protection against the allergic airway inflammation depends on the modulation of spleen dendritic cell function and induction of regulatory T cells in mice.Development of avian influenza virus H5 DNA vaccine and MDP-1 gene of Mycobacterium bovis as genetic adjuvantRecombinant lambda-phage nanobioparticles for tumor therapy in mice models.Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice.A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation.AAV2-mediated in vivo immune gene therapy of solid tumours.Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan.Plasmid-encoded NP73-102 modulates atrial natriuretic peptide receptor signaling and plays a critical role in inducing tolerogenic dendritic cells.
P1433
Q21245503-F83C40F4-5299-4D71-B2A8-69BBD8BB4B9AQ24792050-9ECDF5FC-2704-4D56-B8AC-856B49CAC99AQ24792056-3ECD5E27-0442-4C2A-80E8-CA8A62381278Q24793078-44252AAA-3AAB-4C0F-8214-3DFC4D110D7DQ24793340-D7BCB487-0F6D-4111-87AA-2DB0E782DCE1Q24794695-DF5198E3-8E96-4B1A-950D-D3F6BF9E972AQ24795118-89892EFD-5DB4-463B-A919-A96622492069Q24797260-402E2E5D-E182-4F2D-8BDC-10792C8954C2Q24797282-D6D3B94F-B274-4603-A5AD-55DF85F24A5DQ24798616-09D02CA0-B9DD-4F43-BDDB-10A8EEF613E1Q24800764-DD6E8066-5A86-4CFF-BC84-B7CD19799F46Q24801168-47411917-61FE-4E4D-849E-7E70DF9E9A40Q24801425-1DBEB74E-D76A-44DF-888F-67B3E67A9A90Q24801950-78A035E7-F744-44EE-9BA3-1AAA8AD6C7A4Q24802168-F7E82A21-BB9E-4328-A04D-72C7B611BEA8Q24802324-1D1E0733-A8EF-4B0C-9B9F-6CF4247E15B5Q24804110-3751BB42-39A9-4916-AED8-E79BE2BFF8ACQ24804662-DB8A5BD7-875C-4E86-AC4B-2262977F2A7FQ24804883-2E1EF5FB-B78D-426A-8729-51494E79187EQ24804905-8BA9715D-CC06-4E93-8347-69A7A34530FFQ24806156-5A793EF9-7C95-4FD1-97B1-3D6ADA7DF870Q24806169-287D1C44-DEAD-4BEB-9AC3-41DF1D93AAB8Q24806498-76A6AE5B-1BEA-401F-8CFF-AB42AFBF1D28Q24813890-06087B8A-78AA-4827-A4BF-03F0BE0A8254Q24814041-C5721E45-33FF-4B4B-8799-C64BD7B167C6Q24814838-92EB4437-07F2-4B81-9047-0942A820E7A5Q24816692-416AE417-A58D-42D8-8081-C09DB9EF0070Q24816925-A6DFE81C-1DE4-423E-A07D-C15B4CB18FC9Q25257540-A89E7896-EFE4-4228-BD80-3EA90E0C129EQ28715463-3A179296-BB67-4DF7-9CCC-4522B5052E74Q33369214-AC1CCA08-168B-4D60-8CFE-67A5937D1499Q33465283-816C8AC5-E17A-4A9D-A7CE-635D46FC587CQ33816173-2840ADDE-1A6F-4BD7-B349-F46F47E0DC09Q33921967-4513232F-51E4-46E6-929C-99655060D34CQ33934146-368D581B-4BCA-4B29-A0D3-2577FEB333C3Q34128496-AD1B6034-0D66-43F3-B59D-9BB4BC0F7755Q34330865-8222A89E-4144-4C9C-9242-66A80CC6FC01Q34468330-F67B15B7-5FBB-4BA2-999A-FCB63A16A75AQ34503772-816B7BF1-6D4F-435A-BACD-37C017A03F75Q34515184-41F9CD4B-6842-4068-9876-2FBFEBD0A0E7
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van BioMed Central
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Genetic Vaccines and Therapy
@ast
Genetic Vaccines and Therapy
@en
Genetic Vaccines and Therapy
@es
Genetic Vaccines and Therapy
@it
Genetic Vaccines and Therapy
@nl
type
label
Genetic Vaccines and Therapy
@ast
Genetic Vaccines and Therapy
@en
Genetic Vaccines and Therapy
@es
Genetic Vaccines and Therapy
@it
Genetic Vaccines and Therapy
@nl
prefLabel
Genetic Vaccines and Therapy
@ast
Genetic Vaccines and Therapy
@en
Genetic Vaccines and Therapy
@es
Genetic Vaccines and Therapy
@it
Genetic Vaccines and Therapy
@nl
P3181
P1055
P1058
P1156
P123
P1277
P1476
Genetic Vaccines and Therapy
@en